Catalyst Wire Dossier Catalyst Wire Dossier

Mesalazine oral suspension

mesalazine · Dr. Falk Pharma GmbH
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Mesalazine oral suspension, covering 2023-09-07 to 2023-09-07. Get the full timeline:

Most recent: Clinical Trial Update: Mesalazine Oral Suspension in Active Eosinophilic Esophagitis [Phase 2]

See pricing